Faraone, Stephen V. http://orcid.org/0000-0002-9217-3982
Larsson, Henrik
Article History
Received: 29 August 2017
Revised: 31 January 2018
Accepted: 19 February 2018
First Online: 11 June 2018
Compliance with ethical standards
:
: In the past year, SVF received income, potential income, travel expenses continuing education support and/or research support from Lundbeck, KenPharm, Rhodes, Arbor, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA, Sunovion, Genomind, and NeuroLifeSciences. With his institution, he has US patent US20130217707 A1 for the use of sodium−hydrogen exchange inhibitors in the treatment of ADHD. HL has served as a speaker for Eli-Lilly and Shire and has received research grants from Shire.